Literature DB >> 7903256

Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences.

T Hoffmann1, J Faust, K Neubert, S Ansorge.   

Abstract

A number of natural cytokines are characterized as having dipeptidyl peptidase (DP) IV susceptible N-terminal peptide sequences. Here we demonstrate that oligopeptides with sequences analogous to the N-terminal part of human IL-1 beta, IL-2, TNF-beta and murine IL-6 were hydrolyzed by purified DP IV and aminopeptidase N (AP-N). The rate of DP IV-catalyzed hydrolysis of these peptides was negatively correlated with their chain length. In contrast to these results, no degradation was found under our conditions for the intact recombinant cytokines, IL-1 alpha, IL-1 beta, IL-2, G-CSF and for natural IL-2, independent of whether DP IV and AP-N were used separately or in combination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903256     DOI: 10.1016/0014-5793(93)81609-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironment.

Authors:  Liliana Guzman-Rojas; Roberto Rangel; Ahmad Salameh; Julianna K Edwards; Eleonora Dondossola; Yun-Gon Kim; Alan Saghatelian; Ricardo J Giordano; Mikhail G Kolonin; Fernanda I Staquicini; Erkki Koivunen; Richard L Sidman; Wadih Arap; Renata Pasqualini
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  The activities of six exo-and endopeptidases in the substantia nigra, neostriatum, and cortex of the rat brain.

Authors:  M E Gallegos; M M Zannatha; E G Osornio; A S Sánchez; F A Posadas del rio
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 3.  Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.

Authors:  C Klemann; L Wagner; M Stephan; S von Hörsten
Journal:  Clin Exp Immunol       Date:  2016-05-13       Impact factor: 4.330

4.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.

Authors:  D Reinhold; U Bank; F Bühling; U Lendeckel; J Faust; K Neubert; S Ansorge
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 5.  CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.

Authors:  Chenyang Lu; Mohammad A Amin; David A Fox
Journal:  J Immunol       Date:  2020-01-01       Impact factor: 5.422

6.  Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.

Authors:  Li Su; Jiangying Cao; Yuping Jia; Xiaonan Zhang; Hao Fang; Wenfang Xu
Journal:  ACS Med Chem Lett       Date:  2012-09-21       Impact factor: 4.345

7.  Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.

Authors:  A Banbula; M Bugno; J Goldstein; J Yen; D Nelson; J Travis; J Potempa
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Distribution of dipeptidyl peptidase IV in patients with chronic tonsillitis.

Authors:  Milan Stankovic; Predrag Vlahovic; Verica Avramovic; Miroljub Todorovic
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

9.  Identification of bile canalicular cell surface antigen HAM.4 as dipeptidyl peptidase IV (DPPIV) and characterization of its role in hepatic regeneration after partial hepatectomy in rats.

Authors:  M Tsugiki; Y Kobayashi; T Kawasaki; T Yoshimi
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 10.  The neovasculature homing motif NGR: more than meets the eye.

Authors:  Angelo Corti; Flavio Curnis; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.